Risk and prognostic factors among patients with bacteremia due to Eggerthella lenta

Anaerobe

Volumn 18, Issue 4, 2012, Pages 475-478

  Venugopal, Anilrudh A ^a,b   Szpunar, Susanna ^a   Johnson, Leonard B ^a,b  

^a ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteremia; Eggerthella lenta; Eubacterium lentum; Mortality; Sepsis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME AXETIL; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; FLUCONAZOLE; GENTAMICIN; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; VANCOMYCIN;

ADULT; AGED; ANAEROBIC BACTERIUM; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; COMMENSAL; EGGERTHELLA LENTA; FEMALE; FEVER; GRAM POSITIVE BACTERIUM; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ACTINOBACTERIA; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BACTERIAL INFECTIONS; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

BACILLI (CLASS); EGGERTHELLA LENTA; POSIBACTERIA;

EID: 84864330797     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2012.05.005     Document Type: Article

References (21)

1. Eggerth A.H. The Gram-positive non-spore-bearing anaerobic bacilli of human feces. J Bacteriol 1935, 30:277-299.
2. Moore W.E.C., Cato E.P., Holdeman L.V. Eubacterium lentum (Eggerth) Prevot 1938: emendation of description and designation of the Neotype strain. Int J Syst Bacteriol 1971, 21:299-303.
3. Bokkenheuser V.D., Winter J., Finegold S.M., Sutter V.L., Ritchie A.E., Moore W.E., et al. New markers for Eubacterium lentum. Appl Environ Microbiol 1979, 37:1001-1006.
4. Wade W.G., Downes J., Dymock D., Hiom S.J., Weightman A.J., Dewhirst F.E., et al. The family Coriobacteriaceae: reclassification of Eubacterium exiguum (Poco et al. 1996) and Peptostreptococcus heliotrinreducens (Lanigan 1976) as Slackia exigua gen. nov., comb. nov. and Slackia heliotrinireducens gen. nov., comb. nov., and Eubacterium lentum (Prevot 1938) as Eggerthella lenta gen. nov., comb. nov. Int J Syst Bacteriol 1999, 49(Pt 2):595-600.
5. Bok C.W., Ng Y.S. Eggerthella lenta as a cause of anaerobic spondylodiscitis. Singapore Med J 2009, 50:e393-e396.
6. Lattuada E., Zorzi A., Lanzafame M., Antolini D., Fontana R., Vento S., et al. Cutaneous abscess due to Eubacterium lentum in injection drug user: a case report and review of the literature. J Infect 2005, 51:E71-E72.
7. Moon T., Lin R.Y., Jahn A.F. Fatal frontal sinusitis due to Neisseria sicca and Eubacterium lentum. J Otolaryngol 1986, 15:193-195.
8. Palomino-Nicas J., Gonzalez E., Arroyo A., Canas E., Hernanz W., Pachon J. Pyomyositis due to Eubacterium lentum and Streptococcus constellatus from a periodontal source. Clin Infect Dis 1996, 22:176-178.
9. Rautio M., Saxen H., Siitonen A., Nikku R., Jousimies-Somer H. Bacteriology of histopathologically defined appendicitis in children. Pediatr Infect Dis J 2000, 19:1078-1083.
10. Bourne K.A., Beebe J.L., Lue Y.A., Ellner P.D. Bacteremia due to Bifidobacterium, Eubacterium or Lactobacillus; twenty-one cases and review of the literature. Yale J Biol Med 1978, 51:505-512.
11. Brook I., Frazier E.H. Significant recovery of nonsporulating anaerobic rods from clinical specimens. Clin Infect Dis 1993, 16:476-480.
12. Chan R.C., Mercer J. First Australian description of Eggerthella lenta bacteraemia identified by 16S rRNA gene sequencing. Pathology 2008, 40:409-410.
13. Eng R.H., Suwanagool S., Chmel H., Smith S.M., Tecson-Tumang F., Corrado M. The significance of Eubacterium bacteremia. Am J Gastroenterol 1983, 78:90-93.
14. Landais C., Doudier B., Imbert G., Fenollar F., Brouqui P. Application of rrs gene sequencing to elucidate the clinical significance of Eggerthela lenta infection. J Clin Microbiol 2007, 45:1063-1065.
15. Lau S.K., Woo P.C., Woo G.K., Fung A.M., Wong M.K., Chan K.M., et al. hongkongensis sp. nov. and Eggerthella sinensis sp. nov., two novel Eggerthella species, account for half of the cases of Eggerthella bacteremia. Diagn Microbiol Infect Dis 2004, 49:255-263.
16. Liderot K., Larsson M., Borang S., Ozenci V. Polymicrobial bloodstream infection with Eggerthella lenta and Desulfovibrio desulfuricans. J Clin Microbiol 2010, 48:3810-3812.
17. Thota V.R., Dacha S., Natarajan A., Nerad J. Eggerthella lenta bacteremia in a Crohn's disease patient after ileocecal resection. Future Microbiol 2011, 6:595-597.
18. Wilson W.R., Martin W.J., Wilkowske C.J., Washington J.A. Anaerobic bacteremia. Mayo Clin Proc 1972, 47:639-646.
19. Quan H., Li B., Couris C.M., Fushimi K., Graham P., Hider P., et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 2011, 173:676-682.
20. Wilson J.R., Limaye A.P. Risk factors for mortality in patients with anaerobic bacteremia. Eur J Clin Microbiol Infect Dis 2004, 23:310-316.
21. Laupland K.B., Zahar J.R., Adrie C., Schwebel C., Goldgran-Toledano D., Azoulay E., et al. Determinants of temperature abnormalities and influence on outcome of critical illness. Crit Care Med 2012, 40:1-7.